55 related articles for article (PubMed ID: 1630401)
1. [The determination of serum amino-terminal procollagen type-III propeptide (PIIINP) in occupational exposure to rock wool fiber].
Cavalleri A; Gobba F; Ferrari D; Bacchella L; Robotti M; Mineo F; Pedroni C
Med Lav; 1992; 83(2):127-34. PubMed ID: 1630401
[TBL] [Abstract][Full Text] [Related]
2. [Asbestos fibre lung burden and exposure indices in asbestos-cement workers].
Barbieri PG; Somigliana A; Lombardi S; Girelli R; Benvenuti A
Med Lav; 2009; 100(1):21-8. PubMed ID: 19263869
[TBL] [Abstract][Full Text] [Related]
3. [Changes in serum levels of N-terminal procollagen type III propeptide as an index of postinfarction ventricular remodeling].
Molinari R; Rossi R; Muia N; Castelli A; Modena MG; Mattioli G; Bacchella L; Gobba F
Cardiologia; 1997 Jun; 42(6):627-33. PubMed ID: 9289379
[TBL] [Abstract][Full Text] [Related]
4. Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients.
Teppo AM; Törnroth T; Honkanen E; Grönhagen-Riska C
Transplantation; 2003 Jun; 75(12):2113-9. PubMed ID: 12829921
[TBL] [Abstract][Full Text] [Related]
5. Analytical, physiologic, and clinical validation of a radioimmunoassay for measurement of procollagen type III amino terminal propeptide in serum and bronchoalveolar lavage fluid obtained from dogs.
Schuller S; Valentin S; Remy B; Jespers P; Foulon S; Van Israël N; Clercx C; McEntee K
Am J Vet Res; 2006 May; 67(5):749-55. PubMed ID: 16649905
[TBL] [Abstract][Full Text] [Related]
6. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
7. Propeptide levels of procollagen type IV (NC1) and III (PIIINP) in patients undergoing haemodialysis.
Keller F; Dingeldein K; Ser YL; Schuppan D
Int Urol Nephrol; 1993; 25(3):305-8. PubMed ID: 8225832
[TBL] [Abstract][Full Text] [Related]
8. [Selected markers of subclinical renal damage in men occupationally exposed to mercury vapours].
Rutowski J; Moszczyński P
Przegl Lek; 2006; 63 Suppl 7():65-73. PubMed ID: 17784548
[TBL] [Abstract][Full Text] [Related]
9. External and internal dose in subjects occupationally exposed to ochratoxin A.
Iavicoli I; Brera C; Carelli G; Caputi R; Marinaccio A; Miraglia M
Int Arch Occup Environ Health; 2002 Aug; 75(6):381-6. PubMed ID: 12070633
[TBL] [Abstract][Full Text] [Related]
10. Study on the oxidative stress status among cement plant workers.
Pournourmohammadi S; Khazaeli P; Eslamizad S; Tajvar A; Mohammadirad A; Abdollahi M
Hum Exp Toxicol; 2008 Jun; 27(6):463-9. PubMed ID: 18784198
[TBL] [Abstract][Full Text] [Related]
11. Type III procollagen N-terminal peptides in experimental pulmonary fibrosis and human respiratory diseases.
Watanabe Y; Yamaki K; Yamakawa I; Takagi K; Satake T
Eur J Respir Dis; 1985 Jul; 67(1):10-6. PubMed ID: 2414122
[TBL] [Abstract][Full Text] [Related]
12. [Asbestos substitutes and their biological action. I. Types, use, exposure and MPEL].
Woźniak H; Wiecek E; Stroszejn-Mrowca G; Wojtczak J
Med Pr; 1992; 43(2):159-64. PubMed ID: 1435251
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
Bolarin DM; Swerdlow P; Wallace AM; Littsey L
Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
[TBL] [Abstract][Full Text] [Related]
14. Type III procollagen N-peptide correlates with beta-2-microglobulin in myelomatosis.
Hasselbalch HC; Bjerrum OW; Junker P
Clin Lab Haematol; 1995 Sep; 17(3):237-41. PubMed ID: 8719897
[TBL] [Abstract][Full Text] [Related]
15. [Serum type III procollagen peptide in diagnosis of lung fibrosis due to silicosis and bleomycin toxicity].
Okuno F; Maruyama K; Okazaki I; Arai M; Suzuki H
J UOEH; 1986 Mar; 8 Suppl():355-61. PubMed ID: 2425407
[TBL] [Abstract][Full Text] [Related]
16. [Type III procollagen N-terminal peptide and type IV collagen-7S level in the serum and BALF of patients with non-Hodgkin's lymphoma before and after chemotherapy].
Niitsu N; Umeda M
Rinsho Ketsueki; 1994 Nov; 35(11):1267-75. PubMed ID: 7529840
[TBL] [Abstract][Full Text] [Related]
17. Lung fibre burden in lung cancer cases employed in the rock and slag wool industry.
Soldan K; Pooley FD; Hansen J; Andersen A; Chang-Claude J; Ferro G; Ohgaki H; Skov BG; Cherrie JW; Saracci R; Boffetta P
Ann Occup Hyg; 2006 Apr; 50(3):241-8. PubMed ID: 16371416
[TBL] [Abstract][Full Text] [Related]
18. Ehlers-Danlos syndrome type IV: a subset of patients distinguished by low serum levels of the amino-terminal propeptide of type III procollagen.
Steinmann B; Superti-Furga A; Joller-Jemelka HI; Cetta G; Byers PH
Am J Med Genet; 1989 Sep; 34(1):68-71. PubMed ID: 2816989
[TBL] [Abstract][Full Text] [Related]
19. Serum type III procollagen peptide in asbestos workers: an early indicator of pulmonary fibrosis.
Cavalleri A; Gobba F; Bacchella L; Luberto F; Ziccardi A
Br J Ind Med; 1988 Dec; 45(12):818-23. PubMed ID: 3219307
[TBL] [Abstract][Full Text] [Related]
20. Environmental surveys in the European man-made mineral fiber production industry.
Cherrie J; Dodgson J; Groat S; Maclaren W
Scand J Work Environ Health; 1986; 12 Suppl 1():18-25. PubMed ID: 3026035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
